Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| PRKACA | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence |
|
||||
| PRKACA | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 17.60 | Evidence | |||||
| PRKACA | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 17.60 | Evidence | |||||
| PRKACA | JUNB | JUNB: Transcription factor jun-B | 17.10 | Evidence | |||||
| PRKACA | JUN | JUN: Transcription factor AP-1 | 17.10 | Evidence | |||||
| PRKACA | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 13.40 | Evidence | |||||
| PRKACA | GRIK2 | GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor | 11.60 | Evidence | |||||
| PRKACA | NRAS | NRAS, HRAS1: GTPase NRas precursor | 10.30 | Evidence | |||||
| PRKACA | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 8.92 | Evidence | |||||
| PRKACA | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 8.92 | Evidence | |||||
| PRKACA | GIT2 | N/A | 8.92 | Evidence | |||||
| PRKACA | PRKAR2A | PRKAR2A, PKR2, PRKAR2: cAMP-dependent protein kinase type II-alpha regulatory su | 6.93 | Evidence | |||||
| PRKACA | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 6.80 | Evidence | |||||
| PRKACA | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 6.80 | Evidence | |||||
| PRKACA | SGK3 | SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 | 6.80 | Evidence | |||||
| PRKACA | CHEK1 | CHEK1, CHK1: Serine/threonine-protein kinase Chk1 | 5.74 | Evidence | |||||
| PRKACA | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 5.73 | Evidence | |||||
| PRKACA | PRKAR1A | PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato | 4.84 | Evidence |
|
||||
| PRKACA | MCM3 | MCM3: DNA replication licensing factor MCM3 | 4.26 | Evidence | |||||
| PRKACA | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 4.26 | Evidence | |||||
| PRKACA | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 3.65 | Evidence |
|
||||
| PRKACA | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 3.47 | Evidence | |||||
| PRKACA | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.47 | Evidence | |||||
| PRKACA | GART | GART, PGFT, PRGS: Trifunctional purine biosynthetic protein adenosine-3 [Include | 3.44 | Evidence | |||||
| PRKACA | CDK4 | CDK4: Cell division protein kinase 4 | 2.99 | Evidence | |||||
| PRKACA | ACTG1 | ACTB: Actin, cytoplasmic 1 | 2.99 | Evidence | |||||
| PRKACA | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 2.99 | Evidence | |||||
| PRKACA | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 2.99 | Evidence | |||||
| PRKACA | DLG1 | N/A | 2.28 | Evidence | |||||
| PRKACA | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 2.28 | Evidence | |||||
| PRKACA | SGK | SGK, SGK1: Serine/threonine-protein kinase Sgk1 | 2.28 | Evidence | |||||
| PRKACA | MAPRE1 | MAPRE1: Microtubule-associated protein RP/EB family member 1 | 2.28 | Evidence | |||||
| PRKACA | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 2.28 | Evidence | |||||
| PRKACA | CCNE2 | CCNE2: G1/S-specific cyclin-E2 | 2.17 | Evidence | |||||
| PRKACA | PRKAR2B | N/A | 1.39 | Evidence | |||||
| PRKACA | INSR | INSR: Insulin receptor precursor | 1.16 | Evidence | |||||
| PRKACA | COPB2 | COPB2: Coatomer subunit beta' | 1.15 | Evidence | |||||
| PRKACA | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 1.15 | Evidence | |||||
| PRKACA | CNOT3 | CNOT3, KIAA0691, LENG2, NOT3: CCR4-NOT transcription complex subunit 3 | 1.0 | Evidence | |||||
| PRKACA | RAB7 | RAB7A, RAB7: Ras-related protein Rab-7a | 0.905 | Evidence | |||||
| PRKACA | RAB5A | RAB5A, RAB5: Ras-related protein Rab-5A | 0.36 | Evidence | |||||
| PRKACA | SURF5 | N/A | 0.36 | Evidence | |||||
| PRKACA | STX1A | STX1A, STX1: Syntaxin-1A | 0.318 | Evidence | |||||
| PRKACA | CKS1B | CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 | 0.268 | Evidence | |||||
| PRKACA | TCP1 | CCT1, CCTA, TCP1: T-complex protein 1 subunit alpha | 0.202 | Evidence | |||||
| PRKACA | PYGL | PYGL: Glycogen phosphorylase, liver form | 0.2 | Evidence | |||||
| PRKACA | RPA1 | RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit | 0.16 | Evidence | |||||
| PRKACA | HSPE1 | HSPE1: 10 kDa heat shock protein, mitochondrial | 0.148 | Evidence | |||||
| PRKACA | BRSK1 | BRSK1, KIAA1811, SAD1: BR serine/threonine-protein kinase 1 | 0.142 | Evidence | |||||
| PRKACA | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 0.142 | Evidence | |||||
| PRKACA | MCF2 | MCF2, DBL: Proto-oncogene DBL | 0.142 | Evidence | |||||
| PRKACA | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 0.142 | Evidence | |||||
| PRKACA | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 0.142 | Evidence | |||||
| PRKACA | SQSTM1 | SQSTM1: Uncharacterized protein SQSTM1 | 0.142 | Evidence | |||||
| PRKACA | GAB2 | N/A | 0.142 | Evidence | |||||
| PRKACA | PSCD1 | PSCD1, D17S811E: Cytohesin-1 | 0.142 | Evidence | |||||
| PRKACA | IRS1 | IRS1: Insulin receptor substrate 1 | 0.142 | Evidence | |||||
| PRKACA | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 0.142 | Evidence | |||||
| PRKACA | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 0.142 | Evidence | |||||
| PRKACA | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 0.142 | Evidence | |||||
| PRKACA | PLEK | PLEK, P47: Pleckstrin | 0.142 | Evidence | |||||
| PRKACA | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 0.142 | Evidence | |||||
| PRKACA | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 0.142 | Evidence |
|
||||
| PRKACA | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 0.142 | Evidence | |||||
| PRKACA | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 0.142 | Evidence | |||||
| PRKACA | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 0.142 | Evidence | |||||
| PRKACA | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 0.142 | Evidence | |||||
| PRKACA | HMGA2 | HMGA2, HMGIC: High mobility group protein HMGI-C | 0.142 | Evidence | |||||
| PRKACA | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 0.142 | Evidence | |||||
| PRKACA | LNK | SH2B3, LNK: SH2B adapter protein 3 | 0.142 | Evidence | |||||
| PRKACA | APPL | APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha | 0.142 | Evidence | |||||
| PRKACA | BMX | N/A | 0.142 | Evidence | |||||
| PRKACA | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 0.142 | Evidence | |||||
| PRKACA | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 0.142 | Evidence | |||||
| PRKACA | PSCD2 | N/A | 0.142 | Evidence | |||||
| PRKACA | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 0.142 | Evidence | |||||
| PRKACA | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 0.142 | Evidence | |||||
| PRKACA | ETV1 | ETV1, ER81: ETS translocation variant 1 | 0.142 | Evidence |
|
||||
| PRKACA | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 0.142 | Evidence | |||||
| PRKACA | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 0.142 | Evidence | |||||
| PRKACA | NCF4 | NCF4, SH3PXD4: Neutrophil cytosol factor 4 | 0.142 | Evidence | |||||
| PRKACA | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 0.142 | Evidence |
|
||||
| PRKACA | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 0.142 | Evidence | |||||
| PRKACA | HMGA1 | HMGA1, HMGIY: High mobility group protein HMG-I/HMG-Y | 0.142 | Evidence | |||||
| PRKACA | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 0.142 | Evidence | |||||
| PRKACA | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 0.142 | Evidence | |||||
| PRKACA | GAB1 | GAB1: GRB2-associated-binding protein 1 | 0.142 | Evidence | |||||
| PRKACA | SNCB | SNCB: Beta-synuclein | 0.142 | Evidence | |||||
| PRKACA | DNM3 | DNM3: Uncharacterized protein DNM3 | 0.142 | Evidence | |||||
| PRKACA | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 0.142 | Evidence | |||||
| PRKACA | VASP | VASP: Vasodilator-stimulated phosphoprotein | 0.142 | Evidence |
|
||||
| PRKACA | NSBP1 | NSBP1: Nucleosome-binding protein 1 | 0.142 | Evidence | |||||
| PRKACA | MAP2K5 | N/A | 0.142 | Evidence | |||||
| PRKACA | ARHGEF12 | ARHGEF12, KIAA0382, LARG: Rho guanine nucleotide exchange factor 12 | 0.142 | Evidence | |||||
| PRKACA | IRS2 | IRS2: Insulin receptor substrate 2 | 0.142 | Evidence | |||||
| PRKACA | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 0.142 | Evidence |
|
||||
| PRKACA | HMGN1 | HMGN1, HMG14: Non-histone chromosomal protein HMG-14 | 0.142 | Evidence |
|
||||
| PRKACA | NF2 | NF2, SCH: Merlin | 0.142 | Evidence | |||||
| PRKACA | PLEKHA5 | PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member | 0.142 | Evidence | |||||
| PRKACA | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 0.142 | Evidence | |||||
| PRKACA | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 0.128 | Evidence | |||||
| PRKACA | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 0.128 | Evidence | |||||
| PRKACA | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 0.128 | Evidence |
|
||||
| PRKACA | DOK1 | DOK1: Docking protein 1 | 0.128 | Evidence | |||||
| PRKACA | APBA2 | APBA2, MINT2, X11L: Amyloid beta A4 precursor protein-binding family A member 2 | 0.128 | Evidence | |||||
| PRKACA | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 0.128 | Evidence | |||||
| PRKACA | MSN | MSN: Moesin | 0.128 | Evidence | |||||
| PRKACA | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 0.128 | Evidence | |||||
| PRKACA | DAB2 | DAB2, DOC2: Disabled homolog 2 | 0.128 | Evidence | |||||
| PRKACA | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 0.128 | Evidence | |||||
| PRKACA | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 0.128 | Evidence |
|
||||
| PRKACA | PSCD4 | PSCD4, CYT4: Cytohesin-4 | 0.128 | Evidence | |||||
| PRKACA | STAT3 | 0.128 | Evidence | ||||||
| PRKACA | VAV1 | VAV1, VAV: Proto-oncogene vav | 0.128 | Evidence | |||||
| PRKACA | CCNE1 | CCNE1, CCNE: G1/S-specific cyclin-E1 | 0.128 | Evidence | |||||
| PRKACA | SYK | SYK: Tyrosine-protein kinase SYK | 0.128 | Evidence | |||||
| PRKACA | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 0.128 | Evidence | |||||
| PRKACA | SH3BP5 | N/A | 0.128 | Evidence | |||||
| PRKACA | APS | SH2B2, APS: SH2B adapter protein 2 | 0.128 | Evidence | |||||
| PRKACA | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 0.128 | Evidence | |||||
| PRKACA | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 0.128 | Evidence | |||||
| PRKACA | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 0.128 | Evidence | |||||
| PRKACA | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 0.128 | Evidence | |||||
| PRKACA | RIN1 | RIN1: Ras and Rab interactor 1 | 0.128 | Evidence | |||||
| PRKACA | DGKD | DGKD, KIAA0145: Diacylglycerol kinase delta | 0.128 | Evidence | |||||
| PRKACA | MAPK8IP1 | MAPK8IP1, IB1, JIP1, PRKM8IP: C-jun-amino-terminal kinase-interacting protein 1 | 0.128 | Evidence | |||||
| PRKACA | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 0.128 | Evidence | |||||
| PRKACA | ITSN2 | ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 | 0.128 | Evidence | |||||
| PRKACA | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 0.128 | Evidence | |||||
| PRKACA | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 0.128 | Evidence | |||||
| PRKACA | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 0.128 | Evidence |
|
||||
| PRKACA | PLD1 | PLD1: Phospholipase D1 | 0.128 | Evidence | |||||
| PRKACA | CCNL1 | CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 | 0.128 | Evidence | |||||
| PRKACA | LYN | LYN: Tyrosine-protein kinase Lyn | 0.128 | Evidence | |||||
| PRKACA | EPB41L2 | EPB41L2: Band 4.1-like protein 2 | 0.128 | Evidence | |||||
| PRKACA | CREB1 | CREB1: cAMP response element-binding protein | 0.128 | Evidence | |||||
| PRKACA | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 0.128 | Evidence |
|
||||
| PRKACA | CRKL | CRKL: Crk-like protein | 0.128 | Evidence | |||||
| PRKACA | ARHGEF6 | ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 | 0.128 | Evidence | |||||
| PRKACA | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 0.128 | Evidence | |||||
| PRKACA | CCNB1 | Cyclin B1 | 0.128 | Evidence | |||||
| PRKACA | OSBP | OSBP, OSBP1: Oxysterol-binding protein 1 | 0.128 | Evidence | |||||
| PRKACA | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 0.128 | Evidence | |||||
| PRKACA | TST | TST: Thiosulfate sulfurtransferase | 0.128 | Evidence | |||||
| PRKACA | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 0.128 | Evidence | |||||
| PRKACA | RDX | RDX: Radixin | 0.128 | Evidence | |||||
| PRKACA | HCK | N/A | 0.128 | Evidence | |||||
| PRKACA | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 0.128 | Evidence | |||||
| PRKACA | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 0.128 | Evidence | |||||
| PRKACA | PLCB3 | PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 | 0.128 | Evidence | |||||
| PRKACA | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 0.128 | Evidence | |||||
| PRKACA | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 0.128 | Evidence | |||||
| PRKACA | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 0.128 | Evidence | |||||
| PRKACA | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 0.128 | Evidence | |||||
| PRKACA | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 0.128 | Evidence | |||||
| PRKACA | RANBP2 | RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 | 0.128 | Evidence | |||||
| PRKACA | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 0.128 | Evidence | |||||
| PRKACA | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 0.128 | Evidence | |||||
| PRKACA | CENTB2 | CENTB2, KIAA0041: Centaurin-beta 2 | 0.128 | Evidence | |||||
| PRKACA | SSH1 | SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 | 0.128 | Evidence | |||||
| PRKACA | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 0.128 | Evidence | |||||
| PRKACA | IQSEC1 | IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein | 0.128 | Evidence | |||||
| PRKACA | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 0.128 | Evidence | |||||
| PRKACA | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 0.128 | Evidence | |||||
| PRKACA | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 0.128 | Evidence | |||||
| PRKACA | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 0.128 | Evidence | |||||
| PRKACA | SOS1 | SOS1: Son of sevenless homolog 1 | 0.128 | Evidence | |||||
| PRKACA | ARHGEF7 | N/A | 0.128 | Evidence | |||||
| PRKACA | SSH2 | SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 | 0.128 | Evidence | |||||
| PRKACA | PRKD2 | PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 | 0.128 | Evidence | |||||
| PRKACA | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 0.128 | Evidence | |||||
| PRKACA | JAK1 | 0.128 | Evidence | ||||||
| PRKACA | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 0.128 | Evidence | |||||
| PRKACA | DAB1 | DAB1: Disabled homolog 1 | 0.128 | Evidence | |||||
| PRKACA | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 0.128 | Evidence | |||||
| PRKACA | ATF1 | ATF1: Cyclic AMP-dependent transcription factor ATF-1 | 0.128 | Evidence |
|
||||
| PRKACA | PSMA5 | PSMA5: Proteasome subunit alpha type-5 | 0.128 | Evidence | |||||
| PRKACA | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 0.128 | Evidence | |||||
| PRKACA | CDC25C | CDC25C: M-phase inducer phosphatase 3 | 0.128 | Evidence | |||||
| PRKACA | NCK2 | NCK2: Cytoplasmic protein NCK2 | 0.128 | Evidence | |||||
| PRKACA | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 0.128 | Evidence | |||||
| PRKACA | PSMA2 | PSMA2, PSC3: Proteasome subunit alpha type-2 | 0.128 | Evidence | |||||
| PRKACA | ELMO1 | N/A | 0.128 | Evidence | |||||
| PRKACA | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 0.128 | Evidence | |||||
| PRKACA | PLD2 | PLD2: Phospholipase D2 | 0.128 | Evidence | |||||
| PRKACA | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 0.128 | Evidence |
|
||||
| PRKACA | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 0.128 | Evidence | |||||
| PRKACA | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 0.128 | Evidence | |||||
| PRKACA | ARHGAP12 | ARHGAP12: Rho GTPase-activating protein 12 | 0.128 | Evidence | |||||
| PRKACA | EPB41L1 | EPB41L1, KIAA0338: Band 4.1-like protein 1 | 0.128 | Evidence | |||||
| PRKACA | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 0.128 | Evidence | |||||
| PRKACA | EEF2K | EEF2K: Elongation factor 2 kinase | 0.128 | Evidence |
|
||||
| PRKACA | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 0.128 | Evidence | |||||
| PRKACA | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 0.128 | Evidence | |||||
| PRKACA | CCNH | CCNH: Cyclin-H | 0.128 | Evidence | |||||
| PRKACA | PSMB7 | PSMB7: Proteasome subunit beta type-7 precursor | 0.128 | Evidence | |||||
| PRKACA | CCNT2 | CCNT2: Cyclin-T2 | 0.128 | Evidence | |||||
| PRKACA | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 0.128 | Evidence | |||||
| PRKACA | STMN1 | STMN1, LAP18, OP18: Stathmin | 0.128 | Evidence |
|
||||
| PRKACA | CSK | CSK: Tyrosine-protein kinase CSK | 0.128 | Evidence |
|
||||
| PRKACA | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 0.128 | Evidence | |||||
| PRKACA | ANKS1A | ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A | 0.128 | Evidence | |||||
| PRKACA | VIL2 | N/A | 0.128 | Evidence | |||||
| PRKACA | CCND1 | CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 | 0.128 | Evidence |
|
||||
| PRKACA | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 0.128 | Evidence | |||||
| PRKACA | RASA3 | RASA3: Ras GTPase-activating protein 3 | 0.128 | Evidence | |||||
| PRKACA | C10orf9 | CCNY, C10orf9, CBCP1, CFP1: Cyclin-Y | 0.128 | Evidence | |||||
| PRKACA | PSD | TYL: TYL protein | 0.128 | Evidence | |||||